Anders Niklason

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Lennart Hansson, Lars Lindholm, Leo Niskanen et al. · The Lancet · 1999 · 2K citations

Medicine, Cardiology, Pharmacology +16

Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/β-Blocker–Based Treatment Regimen

Leo Niskanen, Thomas Hedner, Lennart Hansson et al. · Diabetes Care · 2001 · 217 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

<i>IL6</i> Gene Promoter Polymorphisms and Type 2 Diabetes

Cornelia Huth, Iris M. Heid, Caren Vollmert et al. · Diabetes · 2006 · 97 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Development of diabetes is retarded by ACE inhibition in hypertensive patients ??? a subanalysis of the Captopril Prevention Project (CAPPP)

Anders Niklason, Thomas Hedner, Leo Niskanen et al. · Journal of Hypertension · 2004 · 90 citations

Medicine, Cardiology, Internal Medicine +17

Serum leptin and myocardial infarction in hypertension

Susanna M. Wallerstedt, Anna‐Lena Eriksson, Anders Niklason et al. · Blood Pressure · 2004 · 51 citations · Full text

Medicine, Cardiology, Endocrinology +16